Verdane partners with e-health company Evondos to improve home care of elderly in Nordics
SALO/OSLO – Verdane, the specialist Northern European growth equity investor, has announced its investment in Evondos, the Finland-based Nordic leader in automated medicine dispensing services for elderly home care clients. Patient safety and the well-documented reliability of Evondos’ automated medicine dispensing service for independent living and improved medical adherence have made Evondos the partner of choice for over 200 regions and municipalities. Its growth partnership with Verdane aims to develop Evondos’ service offering and extend the company’s market leadership into Northern Europe.
“With less time spent on routine tasks like medicine dispensing, caregivers can spend a bigger part of their visit on much-needed social interactions with their clients. Clinical studies have proven very high medication adherence, around 99%, whilst significantly improving quality of life and independent living at home for seniors with chronic illnesses and reduced cognitive skills. Improved medicine dispensing frees up resources that can be reallocated to parts of our welfare system that need more resources.” says Eetu Koski, CEO at Evondos. He adds: “With a market leading foothold in the Nordics, we are pleased to welcome Verdane onboard to help us expand internationally into Northern Europe.”
Evondos’ vision is to become the global leader in the automated medicine dispensing market. Based in Salo, Finland, Evondos is the Nordic market leader in developing automated medicine dispensing solutions and services. The superior reliability of its dispenser robot, which is capable of reading all multidose sachets in the Nordic market, has made Evondos the leader in its field. Founded in 2007, Evondos today has offices spread across Finland, Norway, Sweden and Denmark supporting over 200 municipal clients, safely distributing over 4 million doses to date. A significant part of the development plan is to further improve Evondos’ offering with added functionalities that improve service usability for clients and caregivers.
Evondos joins a roster of current and former Verdane e-health holdings that include Conscriptor, Sweden’s largest provider of medical transcription services; Max Manus, Scandinavia’s largest developer of speech recognition software for medical documentation; CRF Health, a provider of technology solutions for simplying global clinical trials; and CareTech, a developer of nurse call solutions for elderly and geriatric care.
“We are proud to partner with the best team in the Nordics when it comes to automated medicine dispensing. Evondos is playing a crucial role in improving the quality of life for home care clients and freeing up more time for direct care during home visits. We look forward to joining forces on Evondos’ journey to improve the lives of seniors across Northern Europe,” says Janne Holmia, Principal and responsible for the investment at Verdane.
Eetu Koski, CEO Evondos
+358 50 513 5373
Janne Holmia, Principal Verdane
+358 40 084 3333
Verdane is a specialist growth equity investment firm that partners with ambitious Northern European tech-enabled businesses to help them reach the next stage of international growth. Verdane pioneered portfolio acquisitions in Northern Europe in 2003, and announced a complementary fund strategy entirely dedicated to direct investments in 2018. Verdane’s eight funds hold €1.8bn in total commitments and have made over 120 investments in growth sectors including advanced industry, consumer internet, enterprise software, energy & resource efficiency and financial services. Category leaders backed by Verdane include CAP-Group, Conscriptor, EasyPark, HappyOrNot, Lingit and Max Manus. Verdane’s more than 50 employees, based in Berlin, Copenhagen, Helsinki, London, Oslo and Stockholm, are dedicated to being the best growth partner in Northern Europe. www.verdane.com
Evondos is the leading provider of automated medicine dispensing services in the Nordics. Evondos’ unique service provides significant quality and cost benefits for professional home care organizations. The service enables people in need of medical treatment to get the right medicine at the right time and in the right dosage automatically, which improves patient safety, medical adherence and supports independent life at home. The service is based on advanced technology and consists of an automatic medicine dispensing robot installed in private homes, with a cloudbased control system and service elements. Evondos currently employs 85 people in Finland, Sweden, Norway and Denmark. Evondos’ headquarters and production facilities are located in Salo, Finland. www.evondos.com